Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Contract Development Services, Business Practice, Trends & Forecasts, Contract Manufacturing Services

Think Small, But Smart

Ten years ago, the pharma manufacturing industry looked very different; the age of the blockbuster drug had reached its zenith and sites across the US were being shut down, mothballed, or consolidated. Indeed, many believed the industry was heading to low-cost countries in Asia, lost forever from the West.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Matt Moorcroft

Vice President at Cambrex, New Jersey, US.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register